185 related articles for article (PubMed ID: 38182898)
1. Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.
Jessen M; Gertzmann D; Liss F; Zenk F; Bähner L; Schöffler V; Schulte C; Maric HM; Ade CP; von Eyss B; Gaubatz S
Oncogene; 2024 Feb; 43(8):578-593. PubMed ID: 38182898
[TBL] [Abstract][Full Text] [Related]
2. The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes.
Pattschull G; Walz S; Gründl M; Schwab M; Rühl E; Baluapuri A; Cindric-Vranesic A; Kneitz S; Wolf E; Ade CP; Rosenwald A; von Eyss B; Gaubatz S
Cell Rep; 2019 Jun; 27(12):3533-3546.e7. PubMed ID: 31216474
[TBL] [Abstract][Full Text] [Related]
3. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
4. Somatic Hypermutation of the
Zhang X; Tang JZ; Vergara IA; Zhang Y; Szeto P; Yang L; Mintoff C; Colebatch A; McIntosh L; Mitchell KA; Shaw E; Rizos H; Long GV; Hayward N; McArthur GA; Papenfuss AT; Harvey KF; Shackleton M
Mol Cancer Res; 2019 Jul; 17(7):1435-1449. PubMed ID: 30833299
[TBL] [Abstract][Full Text] [Related]
5. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
6. Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes.
Gründl M; Walz S; Hauf L; Schwab M; Werner KM; Spahr S; Schulte C; Maric HM; Ade CP; Gaubatz S
PLoS Genet; 2020 May; 16(5):e1008818. PubMed ID: 32469866
[TBL] [Abstract][Full Text] [Related]
7. β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma.
Zhang Y; Xu H; Cui G; Liang B; Chen X; Ko S; Affo S; Song X; Liao Y; Feng J; Wang P; Wang H; Xu M; Wang J; Pes GM; Ribback S; Zeng Y; Singhi A; Schwabe RF; Monga SP; Evert M; Tang L; Calvisi DF; Chen X
Gastroenterology; 2022 Aug; 163(2):481-494. PubMed ID: 35489428
[TBL] [Abstract][Full Text] [Related]
8. Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth.
Koo JH; Plouffe SW; Meng Z; Lee DH; Yang D; Lim DS; Wang CY; Guan KL
Genes Dev; 2020 Jan; 34(1-2):72-86. PubMed ID: 31831627
[TBL] [Abstract][Full Text] [Related]
9. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
[TBL] [Abstract][Full Text] [Related]
10. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers.
Howard A; Bojko J; Flynn B; Bowen S; Jungwirth U; Walko G
Exp Dermatol; 2022 Oct; 31(10):1477-1499. PubMed ID: 35913427
[TBL] [Abstract][Full Text] [Related]
12. YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth.
Li X; Zhuo S; Cho YS; Liu Y; Yang Y; Zhu J; Jiang J
EMBO J; 2023 Feb; 42(4):e112184. PubMed ID: 36588499
[TBL] [Abstract][Full Text] [Related]
13. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
[TBL] [Abstract][Full Text] [Related]
14. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
[TBL] [Abstract][Full Text] [Related]
15. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation.
He L; Pratt H; Gao M; Wei F; Weng Z; Struhl K
Elife; 2021 Aug; 10():. PubMed ID: 34463254
[TBL] [Abstract][Full Text] [Related]
16. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.
Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335
[TBL] [Abstract][Full Text] [Related]
17. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.
Yao F; Zhou Z; Kim J; Hang Q; Xiao Z; Ton BN; Chang L; Liu N; Zeng L; Wang W; Wang Y; Zhang P; Hu X; Su X; Liang H; Sun Y; Ma L
Nat Commun; 2018 Jun; 9(1):2269. PubMed ID: 29891922
[TBL] [Abstract][Full Text] [Related]
18. Identification of a derivative of the alkaloid emetine as an inhibitor of the YAP-TEAD interaction and its potential as an anticancer agent.
Sekine S; Takase S; Hayase R; Noritsugu K; Maemoto Y; Ichikawa Y; Ogawa K; Kondoh Y; Osada H; Yoshida M; Ito A
Biosci Biotechnol Biochem; 2023 Apr; 87(5):501-510. PubMed ID: 36809780
[TBL] [Abstract][Full Text] [Related]
19. The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.
Zhang X; Yang L; Szeto P; Abali GK; Zhang Y; Kulkarni A; Amarasinghe K; Li J; Vergara IA; Molania R; Papenfuss AT; McLean C; Shackleton M; Harvey KF
Oncogene; 2020 Jul; 39(30):5267-5281. PubMed ID: 32561850
[TBL] [Abstract][Full Text] [Related]
20. TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy.
Zhang X; Sun F; Qiao Y; Zheng W; Liu Y; Chen Y; Wu Q; Liu X; Zhu G; Chen Y; Yu Y; Pan Q; Wang J
Cell Rep; 2017 Oct; 21(5):1227-1239. PubMed ID: 29091762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]